Principal Scientist
Frontage Laboratories, Inc.
Exton, Pennsylvania
Yongzhong Zhao, Ph.D., is a Principal Scientist of Frontage Labs, has been successively developing Biomarker/ADA/NAb, gene cell therapy regulated assays, supporting an array of pharmaceutical farms. Yongzhong has twenty-year bioanalytical experience in both academic and industrial settings. Of note, He is actively developing humoral and cellular immunogenicity assays with GCLP compliance, as well as GMP analytics of gene and cell therapy products, including critical quality attributes assessment of mRNA vaccines, AAV and Lentivirus-based gene therapy products.
Disclosure information not submitted.
Cell-Based NAB Assays: Aligning Cell Models with Drug MOA
Monday, October 21, 2024
3:00 PM – 3:15 PM MT